{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=intravitreal+injection+of+triamcinolone+acetonide", "query": { "intervention": "intravitreal injection of triamcinolone acetonide" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 27, "total_pages": 3, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=intravitreal+injection+of+triamcinolone+acetonide&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-10-02T04:46:22.751Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT02949024", "title": "Suprachoroidal Injection of CLS-TA Alone or With Aflibercept in Subjects With Diabetic Macular Edema", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Diabetic Macular Edema" ], "interventions": [ { "name": "IVT Aflibercept", "type": "DRUG" }, { "name": "SC CLS-TA", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Clearside Biomedical, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 20, "start_date": "2016-11-10", "completion_date": "2017-10-17", "has_results": true, "last_update_posted_date": "2021-05-13", "last_synced_at": "2026-10-02T04:46:22.751Z", "location_count": 2, "location_summary": "Mountain View, California • The Woodlands, Texas", "locations": [ { "city": "Mountain View", "state": "California" }, { "city": "The Woodlands", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT02949024" }, { "nct_id": "NCT00445003", "title": "Laser-Ranibizumab-Triamcinolone for Proliferative Diabetic Retinopathy", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Proliferative Diabetic Retinopathy", "Diabetic Macular Edema" ], "interventions": [ { "name": "Ranibizumab", "type": "DRUG" }, { "name": "Triamcinolone Acetonide", "type": "DRUG" }, { "name": "Sham injection", "type": "BEHAVIORAL" }, { "name": "Focal/grid laser", "type": "PROCEDURE" } ], "intervention_types": [ "DRUG", "BEHAVIORAL", "PROCEDURE" ], "sponsor": "Jaeb Center for Health Research", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 333, "start_date": "2007-03", "completion_date": "2010-07", "has_results": true, "last_update_posted_date": "2016-08-26", "last_synced_at": "2026-10-02T04:46:22.751Z", "location_count": 56, "location_summary": "Artesia, California • Beverly Hills, California • Irvine, California + 46 more", "locations": [ { "city": "Artesia", "state": "California" }, { "city": "Beverly Hills", "state": "California" }, { "city": "Irvine", "state": "California" }, { "city": "Loma Linda", "state": "California" }, { "city": "Palm Springs", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00445003" }, { "nct_id": "NCT03126786", "title": "Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular Edema", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Diabetic Macular Edema" ], "interventions": [ { "name": "IVT aflibercept", "type": "DRUG" }, { "name": "Sham SC", "type": "DRUG" }, { "name": "SC CLS-TA", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Clearside Biomedical, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 71, "start_date": "2017-07-11", "completion_date": "2018-04-17", "has_results": true, "last_update_posted_date": "2021-05-13", "last_synced_at": "2026-10-02T04:46:22.751Z", "location_count": 29, "location_summary": "Phoenix, Arizona • Tucson, Arizona • Bakersfield, California + 25 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Bakersfield", "state": "California" }, { "city": "Beverly Hills", "state": "California" }, { "city": "Mountain View", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03126786" }, { "nct_id": "NCT02294656", "title": "Acute Pseudophakic Cystoid Macular Edema Treatment Trial: Intravitreal Ranibizumab Versus Triamcinolone Acetonide", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "CYSTOID MACULAR EDEMA" ], "interventions": [ { "name": "Ranibizumab,", "type": "DRUG" }, { "name": "Triamcinolone acetonide", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Soll Eye", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 4, "start_date": "2014-11", "completion_date": "2018-09", "has_results": false, "last_update_posted_date": "2018-09-11", "last_synced_at": "2026-10-02T04:46:22.751Z", "location_count": 1, "location_summary": "Philadelphia, Pennsylvania", "locations": [ { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT02294656" }, { "nct_id": "NCT00071227", "title": "Eye Injections of Triamcinolone Acetonide for Retinal Blood Vessel Disorders", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Macular Degeneration", "Retinal Vein Occlusion" ], "interventions": [ { "name": "Triamcinolone Acetonide (TAC-PF)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "National Eye Institute (NEI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 16, "start_date": "2003-10-15", "completion_date": "2007-08-15", "has_results": false, "last_update_posted_date": "2017-07-02", "last_synced_at": "2026-10-02T04:46:22.751Z", "location_count": 1, "location_summary": "Bethesda, Maryland", "locations": [ { "city": "Bethesda", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT00071227" }, { "nct_id": "NCT02255032", "title": "Suprachoroidal Injection of Triamcinolone Acetonide in Subjects With Macular Edema Following Non-Infectious Uveitis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Uveitis", "Macular Edema", "Uveitis, Posterior", "Uveitis, Anterior", "Panuveitis", "Uveitis, Intermediate" ], "interventions": [ { "name": "4 mg CLS-TA", "type": "DRUG" }, { "name": "0.8 mg CLS-TA", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Clearside Biomedical, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 22, "start_date": "2014-10", "completion_date": "2016-01", "has_results": true, "last_update_posted_date": "2021-02-08", "last_synced_at": "2026-10-02T04:46:22.751Z", "location_count": 11, "location_summary": "Miami, Florida • Atlanta, Georgia • Chicago, Illinois + 8 more", "locations": [ { "city": "Miami", "state": "Florida" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Waltham", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT02255032" }, { "nct_id": "NCT00242580", "title": "A Safety and Efficacy Study Comparing the Combination Treatments of Verteporfin Therapy Plus One of Two Different Doses of Intravitreal Triamcinolone Acetonide and the Verteporfin Therapy Plus Intravitreal Pegaptanib", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Macular Degeneration", "Choroidal Neovascularization" ], "interventions": [ { "name": "Verteporfin photodynamic therapy", "type": "DRUG" }, { "name": "Pegaptanib", "type": "DRUG" }, { "name": "Triamcinolone acetonide", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "50 Years", "maximum_age": null, "sex": "ALL", "summary": "50 Years and older" }, "enrollment_count": 111, "start_date": "2005-09", "completion_date": null, "has_results": true, "last_update_posted_date": "2016-03-31", "last_synced_at": "2026-10-02T04:46:22.751Z", "location_count": 1, "location_summary": "Austin, Texas", "locations": [ { "city": "Austin", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00242580" }, { "nct_id": "NCT02980874", "title": "Suprachoroidal Injection of Triamcinolone Acetonide With IVT Aflibercept in Subjects With Macular Edema Following RVO", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Macular Edema", "Retinal Vein Occlusion" ], "interventions": [ { "name": "suprachoroidal CLS-TA", "type": "DRUG" }, { "name": "suprachoroidal sham", "type": "DRUG" }, { "name": "IVT aflibercept", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Clearside Biomedical, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 460, "start_date": "2017-01-31", "completion_date": "2018-12-10", "has_results": true, "last_update_posted_date": "2021-04-14", "last_synced_at": "2026-10-02T04:46:22.751Z", "location_count": 58, "location_summary": "Peoria, Arizona • Phoenix, Arizona • Tucson, Arizona + 51 more", "locations": [ { "city": "Peoria", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT02980874" }, { "nct_id": "NCT02374060", "title": "PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema Trial", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Macular Edema", "Uveitis" ], "interventions": [ { "name": "Periocular triamcinolone 40 mg", "type": "DRUG" }, { "name": "Intravitreal triamcinolone 4 mg", "type": "DRUG" }, { "name": "Dexamethasone intravitreal implant", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "JHSPH Center for Clinical Trials", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 192, "start_date": "2015-06-16", "completion_date": "2018-01-04", "has_results": true, "last_update_posted_date": "2018-12-04", "last_synced_at": "2026-10-02T04:46:22.751Z", "location_count": 23, "location_summary": "Los Angeles, California • San Francisco, California • Miami, Florida + 17 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Miami", "state": "Florida" }, { "city": "Tampa", "state": "Florida" }, { "city": "Atlanta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT02374060" }, { "nct_id": "NCT05811351", "title": "A Study to Evaluate Intravitreal JNJ-81201887 (AAVCAGsCD59) Compared to Sham Procedure for the Treatment of Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Geographic Atrophy" ], "interventions": [ { "name": "JNJ-81201887", "type": "DRUG" }, { "name": "Prednisone", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" }, { "name": "Triamcinolone", "type": "DRUG" }, { "name": "Sham Procedure", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Janssen Research & Development, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "60 Years", "maximum_age": null, "sex": "ALL", "summary": "60 Years and older" }, "enrollment_count": 305, "start_date": "2023-03-06", "completion_date": "2026-02-23", "has_results": false, "last_update_posted_date": "2026-03-13", "last_synced_at": "2026-10-02T04:46:22.751Z", "location_count": 79, "location_summary": "Phoenix, Arizona • Tucson, Arizona • Fullerton, California + 66 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Fullerton", "state": "California" }, { "city": "Huntington Beach", "state": "California" }, { "city": "La Jolla", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05811351" } ] }